Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis

When to add anti-angiogenesis drugs to EGFR-mutated metastatic non–small cell lung cancer patients: A real-world study from Taiwan

11 p | 10 | 3

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma

9 p | 7 | 2

Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation

12 p | 2 | 2

Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer

13 p | 1 | 1

The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer

10 p | 9 | 1

Epidermal growth factor receptor mutations in non-small cell lung cancer patients from a single institution in Vietnam

7 p | 8 | 1

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study

7 p | 14 | 0

Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: The support trial

7 p | 11 | 0

Evaluating the prognostic value of ERCC1 and thymidylate synthase expression and the epidermal growth factor receptor mutation status in adenocarcinoma non-small-cell lung cancer

8 p | 13 | 0